Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 1
Submit an article Journal homepage
1,782
Views
38
CrossRef citations to date
0
Altmetric
Author's View

Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota

Jonathan M. PittInstitut de Cancérologie Gustave Roussy Cancer Campus (GRCC), Villejuif, France;INSERM Unit U1015, Villejuif, France;Faculté de Médecine, Université Paris Sud, Université Paris-Saclay, Le Kremlin Bicêtre, FranceCorrespondence[email protected] [email protected]
,
Marie VétizouInstitut de Cancérologie Gustave Roussy Cancer Campus (GRCC), Villejuif, France;INSERM Unit U1015, Villejuif, France;Faculté de Médecine, Université Paris Sud, Université Paris-Saclay, Le Kremlin Bicêtre, France
,
Ivo Gomperts BonecaInstitut Pasteur, Unit of Biology and Genetics of the Bacterial Cell Wall, Paris, France;INSERM, Equipe Avenir, Paris, France
,
Patricia LepageInstitut National de la Recherche Agronomique (INRA), Micalis-UMR1319, Jouy-en-Josas, France
,
Mathias ChamaillardUniversity of Lille, CNRS, INSERM, Center Hospitalier Régional Universitaire de Lille, Institut Pasteur de Lille, U1019, UMR 8204, Center d’Infection et d’Immunité de Lille (CIIL), Lille, France
&
Laurence ZitvogelInstitut de Cancérologie Gustave Roussy Cancer Campus (GRCC), Villejuif, France;INSERM Unit U1015, Villejuif, France;Faculté de Médecine, Université Paris Sud, Université Paris-Saclay, Le Kremlin Bicêtre, France;INSERM Unit U932, Institut Curie, Paris Cedex 05, France;Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, FranceCorrespondence[email protected] [email protected]
Article: e1132137 | Received 09 Dec 2015, Accepted 11 Dec 2015, Published online: 23 Jan 2017

References

  • Eberl G. A new vision of immunity: homeostasis of the superorganism. Mucosal Immunol. 2010; 3:450-60; PMID:20445502; http://dx.doi.org/10.1038/mi.2010.20
  • Zitvogel L, Galluzzi L, Viaud S, Vetizou M, Daillere R, Merad M, Kroemer G. Cancer and the gut microbiota: an unexpected link. Sci. Transl. Med. 2015; 7:271ps1; PMID:25609166; http://dx.doi.org/10.1126/scitranslmed.3010473
  • Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013; 342:971-6; PMID:24264990; http://dx.doi.org/10.1126/science.1240537
  • Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013; 342:967-70; PMID:24264989; http://dx.doi.org/10.1126/science.1240527
  • Vetizou M, Pitt JM, Daillere R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 2015; 350:1079-84; PMID:26541610; http://dx.doi.org/10.1126/science.aad1329
  • Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466
  • Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D et al. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J. Clin. Oncol. 2006; 24:2283-9; PMID:16710025; http://dx.doi.org/10.1200/JCO.2005.04.5716
  • Dasgupta S, Erturk-Hasdemir D, Ochoa-Reparaz J, Reinecker HC, Kasper DL. Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms. Cell Host Microbe 2014; 15:413-23; PMID:24721570; http://dx.doi.org/10.1016/j.chom.2014.03.006
  • Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 2015; 350:1084-9; PMID:26541606; http://dx.doi.org/10.1126/science.aac4255

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.